Bitte verwenden Sie diesen Link, um diese Publikation zu zitieren, oder auf sie als Internetquelle zu verweisen: https://hdl.handle.net/10419/261893 
Erscheinungsjahr: 
2021
Quellenangabe: 
[Journal:] BRQ Business Research Quarterly [ISSN:] 2340-9436 [Volume:] 24 [Issue:] 1 [Publisher:] Sage Publishing [Place:] London [Year:] 2021 [Pages:] 91-111
Verlag: 
Sage Publishing, London
Zusammenfassung: 
We analyze the weaknesses of meta-analyses (MAs) in management research using as benchmark a scientific field where this technique shows a longer tradition: clinical research. We suggest four areas in which management research MA practices should improve: (1) availability of information and replicability of primary research, (2) correct application of statistical support, (3) execution of heterogeneity analyses, and (4) standardization of result reporting. Using a representative MA on an operations management topic, we identify qualitatively the aspects to be improved at each stage. We show the different results that could have been achieved by following standard procedures in clinical research, incorporating different "good practices" from this research field. Overall, these recommendations aim at improving the transparency and replicability of MAs, which can not only facilitate the accumulation of scientific knowledge but also intensify the dialogue between academia and practitioners.
Schlagwörter: 
Meta-analysis
"good practices"
transparency
replicability
management
clinical research
JEL: 
C01
M11
M01
Persistent Identifier der Erstveröffentlichung: 
Creative-Commons-Lizenz: 
cc-by-nc-nd Logo
Dokumentart: 
Article

Datei(en):
Datei
Größe
1.39 MB





Publikationen in EconStor sind urheberrechtlich geschützt.